These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 16829800

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
    Ruiz-Moreno JM, Montero JA, Zarbin MA.
    Retina; 2007; 27(4):458-61. PubMed ID: 17420698
    [Abstract] [Full Text] [Related]

  • 3. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [Abstract] [Full Text] [Related]

  • 4. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF, Sorenson J, Maranan L.
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [Abstract] [Full Text] [Related]

  • 5. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [Abstract] [Full Text] [Related]

  • 8. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ, Schmidt-Erfurth U.
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.
    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.
    Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):339-44. PubMed ID: 17805556
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.
    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.
    Ophthalmic Surg Lasers Imaging; 2006 Mar; 37(6):455-61. PubMed ID: 17152538
    [Abstract] [Full Text] [Related]

  • 15. Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.
    Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ.
    Ophthalmology; 2005 Nov; 112(11):1896-903. PubMed ID: 16214216
    [Abstract] [Full Text] [Related]

  • 16. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
    Roth DB, Kulkarni KM, Walsman S, Modi A.
    Ophthalmic Surg Lasers Imaging; 2009 Nov; 40(5):467-71. PubMed ID: 19772270
    [Abstract] [Full Text] [Related]

  • 17. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.
    Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT, Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA.
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [Abstract] [Full Text] [Related]

  • 19. Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.
    Schadlu R, Kymes SM, Apte RS.
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1667-72. PubMed ID: 17583819
    [Abstract] [Full Text] [Related]

  • 20. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS, Shah GK, Blinder KJ, Ryan EH, Mittra RA, Tewari A.
    Retina; 2006 Nov; 26(9):988-93. PubMed ID: 17151484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.